Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostatic cancer. An overview.

L Denis1, C Mahler

  • 1Department of Urology-Endocrinology, Algemeen Ziekenhuis, Middelheim, Antwerp, Belgium.

Acta Oncologica (Stockholm, Sweden)
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety, feasibility, and technical success of percutaneous cryoablation to treat vascular anomalies of the extremities.

Clinical radiology·2025
Same author

Paediatric sclerotherapy of vascular anomalies of the hand and digits.

Clinical radiology·2025
Same author

Real life data of ONC201 (dordaviprone) in pediatric and adult H3K27-altered recurrent diffuse midline glioma: Results of an international academia-driven compassionate use program.

European journal of cancer (Oxford, England : 1990)·2024
Same author

The effect of buzzy®, DistrACTION® cards on reducing pediatric pain and fear during blood collection in the rheumatology polyclinic: A randomized controlled trial.

Journal of pediatric nursing·2023
Same author

Opening up a tailored tutor qualification program for medical students to other healthcare students - a mixed-method study.

BMC medical education·2022
Same author

Failure of total hypophysectomy to remove intrasellar microadenoma in cushing's disease.

Endocrine pathology·2020
Same journal

Pathological characteristics and prognosis of very young patients with early breast cancer: a comparative analysis with older patients.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Recent survival trends in the most fatal cancers in the Nordic countries: gains in some but not in all.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

First-in-human quantitative [¹⁵O]H₂O PET imaging of tumour blood flow at rest and during exercise in lymphoma patients.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Starshot field configuration in the linac isocentre size determination: a comparison of film and electronic portal imaging device measurements.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Perspectives on artificial intelligence-generated chronic disease risk predictions in early breast cancer: an international survey among radiation oncologists.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Evaluation of 3D-CRT vs. VMAT for radiotherapy of whole breast with simultaneous integrated boost.

Acta oncologica (Stockholm, Sweden)·2026
See all related articles

Finding the right prostate cancer treatment is challenging due to tumor variability. Personalized treatment selection requires ongoing trials, new drug development, and basic research into cancer cell behavior.

Area of Science:

  • Oncology
  • Urology

Background:

  • Prostate cancer treatment selection is complex due to diverse tumor characteristics and patient prognoses.
  • Current treatment strategies often involve tailoring therapy based on prognostic factors, stage, and grade.

Purpose of the Study:

  • To highlight the challenges in achieving reliable study results for prostate cancer.
  • To emphasize the need for improved treatment selection strategies in prostate cancer care.

Main Methods:

  • Review of current challenges in prostate cancer research and treatment.
  • Discussion of factors influencing treatment decisions, including tumor characteristics and patient prognosis.

Main Results:

  • Scarcity of reliable study results in prostate cancer is attributed to tumor heterogeneity.

Related Experiment Videos

  • Treatment selection is influenced by prognostic factors, with 'soft' treatments for good prognosis and aggressive treatments for poor prognosis.

    • Conclusions:

    • Optimizing prostate cancer treatment requires better patient stratification and understanding of tumor biology.
    • Future advancements depend on randomized trials, novel drug development, and fundamental research on cancer cell growth and invasiveness.